TWISYNT TECHNOLOGIES PRIVATE LIMITED

About Twisynt Technologies Private Limited
Twisynt Technologies Private Limited is an Indian health-tech startup dedicated to transforming kidney care through intelligent, non‑invasive wearable devices. The company is currently focused on TinySense, a next‑generation wearable that provides non‑invasive, real‑time potassium monitoring specifically for patients with Chronic Kidney Disease (CKD) and those on dialysis.

Founded and led by Vismaya S, Twisynt is building affordable, easy‑to‑use medical devices that empower patients and clinicians with continuous, actionable insights into potassium levels, helping to prevent life‑threatening emergencies like hyperkalemia and hypokalemia.

Our Mission: Smarter Kidney Care
Millions of CKD and dialysis patients in India and globally live with the constant risk of sudden potassium imbalance, which can lead to arrhythmia, cardiac arrest, and hospitalization. Traditional monitoring relies on periodic blood tests, which often miss dangerous fluctuations between visits.

Twisynt’s mission is to close this gap by bringing continuous, non‑invasive potassium monitoring into everyday life. With TinySense, the goal is to:

  • Detect rising or falling potassium levels in real time

  • Alert patients and clinicians early, before symptoms become severe

  • Reduce dependence on frequent blood draws and hospital visits

  • Enable proactive, data‑driven management of CKD and dialysis care


TinySense: Wearable Potassium Monitoring for CKD & Dialysis
TinySense is a wearable device designed to continuously track potassium levels without needles or blood tests. It is being developed specifically for:

  • Patients with Chronic Kidney Disease (CKD)

  • Patients on hemodialysis or peritoneal dialysis

  • Those at high risk of hyperkalemia (high potassium) or hypokalemia (low potassium)


Key benefits of TinySense

  • Non‑invasive monitoring

  • No needles or blood samples required; comfortable for daily wear at home, work, or during dialysis sessions.

  • Real‑time potassium tracking

  • Continuously monitors potassium trends, not just isolated lab values, so changes are seen as they happen.

  • Early alerts for imbalance

  • Sends timely warnings when potassium moves toward dangerous levels, enabling faster intervention.

  • Fewer blood tests & hospital visits

  • Reduces the burden of frequent lab visits and emergency admissions by enabling proactive home monitoring.

  • Empowered patient & clinician decisions

  • Provides continuous data that both patients and doctors can use to adjust diet, medications, and dialysis plans more precisely.


Leadership & Team
Twisynt Technologies is founded and driven by Vismaya S, whose vision is to make advanced kidney care accessible and affordable through innovative medical devices. Under her leadership, the team is focused on building clinically relevant, user‑centric solutions that integrate seamlessly into the lives of CKD and dialysis patients.

Company Details
Company Name: Twisynt Technologies Private Limited

Founder & Director: Vismaya S

Office Address (Incubation / R&D):
MSMF, Mazumdar Shaw Medical Center, Hosur Rd, Bommasandra Industrial Area, Bengaluru, Bommasandra, Karnataka 560099

Registered Address:
Ward No. 14, Thyagaraja Road, Bangalore, Karnataka, India

Website: https://twisynt.com

Why Twisynt Matters
For CKD and dialysis patients, potassium balance is a silent but critical factor in daily survival. TinySense aims to turn potassium monitoring from a reactive, lab‑based process into a proactive, continuous, and patient‑friendly experience. By combining wearable technology with real‑time alerts and actionable insights, Twisynt is working to:

  • Improve safety and quality of life for kidney patients

  • Reduce preventable hospitalizations and emergency events

  • Support clinicians with better data for personalized care

  • Make advanced monitoring accessible across urban and rural India


Twisynt Technologies is proud to be building this future from Bengaluru, with a strong commitment to innovation, affordability, and impact in kidney care.

Leave a Reply

Your email address will not be published. Required fields are marked *